Category: Products & Tech

mannkind logo

MannKind Seeks FDA Approval for Inhaled Insulin

MannKind Corporation has resubmitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of AFREZZA (insulin human [rDNA origin]) Inhalation Powder with an indication to improve glycemic control in adults with type 1 or type 2 diabetes.
0 Shares
Diabetes Test Strips

Why You Should Worry About the Accuracy of Your Glucose Test Strips

CMS recently rolled out competitive bidding for glucose test strips, a highly controversial process which set the reimbursement amounts that Medicare is willing to pay for glucose test strips. These new prices went into effect on July 1, 2013. You can read Medicare’s summary of the changes here; as the New York Times reported (in a poorly researched article that does not acknowledge any potential quality or safety issues), whereas Medicare used to pay $77.90 for 100 test strips, it now will pay $22.47 – a 72% reduction.
0 Shares
NIH Logo

Volunteers Needed for NIH Diabetes Study

If you've been diagnosed with type 2 diabetes in the last 5 years, you may be eligible to help scientists test treatments by participating in an NIH study. NIH has launched a long-term clinical trial called the GRADE study. Researchers will examine the benefits and risks of common diabetes drugs used with metformin.
0 Shares
novamax-diabetes-care-logo

Nova Diabetes Care Recalls Test Strips

Nova Diabetes Care is recalling of 21 lots of the Nova Max Glucose Test Strips distributed both in the USA and outside the continental USA. Nova Max Plus glucose meter kits that include test strips from the recalled lots are also included in the recall.
0 Shares